CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-30 | CLARK IAN T Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2016-12-22 | Biller Scott Chief Scientific Officer | Gift | −7,800 | 40,470 | ||
| 2016-11-14 | Biller Scott Chief Scientific Officer | Sale | −5,000 | $65.00 | $325K | 6,000 |
| 2016-11-14 | Biller Scott Chief Scientific Officer | Option exercise | +6,889 | $0.47 | $3K | 55,159 |
| 2016-11-14 | Biller Scott Chief Scientific Officer | Option exercise | +14,091 | $9.05 | $128K | 69,250 |
| 2016-11-14 | Biller Scott Chief Scientific Officer | Option exercise | +6,520 | $31.64 | $206K | 75,770 |
| 2016-11-14 | Biller Scott Chief Scientific Officer | Sale | −27,500 | $65.00 | $1.8M | 48,270 |
| 2016-11-14 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −6,889 | 5,474 | ||
| 2016-11-14 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −14,091 | 20,000 | ||
| 2016-11-14 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −6,520 | 35,286 | ||
| 2016-11-10 | Biller Scott Chief Scientific Officer | Sale | −2,128 | $60.00 | $128K | 11,000 |
| 2016-11-09 | Biller Scott Chief Scientific Officer | Sale | −2,872 | $60.00 | $172K | 13,128 |
| 2016-11-07 | Alenson Carman Principal Accounting Officer | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2016-10-27 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $48.97 | $31K | 107,778 |
| 2016-10-27 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $48.97 | $31K | 107,818 |
| 2016-10-26 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $48.91 | $31K | 108,405 |
| 2016-10-26 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $48.91 | $31K | 108,443 |
| 2016-10-05 | Biller Scott Chief Scientific Officer | Sale | −5,000 | $55.00 | $275K | 16,000 |
| 2016-09-28 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $54.00 | $34K | 109,032 |
| 2016-09-28 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $54.00 | $34K | 109,068 |
Page 79 of 80 · 1,590 trades